Novo Nordisk | NVO - Satış Ve Yönetim Giderleri





Satış Ve Yönetim Giderleri Değişiklik Tarih
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Aurora Cannabis CAD 41.4M 781K 2026-03
Bausch Health Companies USD 901M 88M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Canopy Growth CAD 31.17M 2.27M 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Drreddys Laboratories INR 14.47B 12.45B 2026-03
Eli Lilly USD 2.93B 198M 2026-03
GlaxoSmithKline GBP 2.19B 75M 2026-06
Merck USD 2.67B 180M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.24B 101M 2026-06
Novo Nordisk DKK 13.22B 4.22B 2026-03
Novo Nordisk DKK 2.86B 13.25B 2025-06
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Sanofi EUR 2.63B 307M 2026-06
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Zoetis USD 588M 31M 2026-03